← Mechanisms of action
FLT4
SINGLE PROTEINHomo sapiens
Preferred name: Vascular endothelial growth factor receptor 3 ChEMBL ↗
Linked proteins
Drugs acting on this target (13)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| Acrizanib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| anlotinib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| anrotenib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| esk981 | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| eyp-1901 | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| famitinib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| imc-3c5 | Inhibitor | experimental | mAb | FLT4 inhibitor |
| jnj-26483327 | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| sunitinib (sutent) | Inhibitor | approved | Small molecule | Vascular endothelial growth factor receptor 3 inhibitor |
| surufatinib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| syha1813 | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| telatinib | Inhibitor | experimental | Small molecule | FLT4 inhibitor |
| telatinib mesylate | Inhibitor | experimental | Small molecule | FLT4 inhibitor |